152 related articles for article (PubMed ID: 8482064)
21. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
Ki SH; Choi JH; Kim CW; Kim SG
Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
[TBL] [Abstract][Full Text] [Related]
22. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
23. Treatment of acute alcohol intoxication: The role of metadoxine.
Mirijello A; Addolorato G
Eur J Intern Med; 2023 Apr; 110():128. PubMed ID: 36797119
[No Abstract] [Full Text] [Related]
24. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
25. MMPI and drug treatment in alcohol withdrawal.
Pena-Ramos A; Hornberger R
J Clin Psychiatry; 1979 Aug; 40(8):361-4. PubMed ID: 468763
[TBL] [Abstract][Full Text] [Related]
26. [Metadoxine in the treatment of vomiting in uremic patients under dialysis treatment].
Di Paolo N; De Mia M; Gaggiotti E
Clin Ter; 1984 Aug; 110(3):221-9. PubMed ID: 6237861
[No Abstract] [Full Text] [Related]
27. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
28. Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.
Higuera-de la Tijera F; Servín-Caamaño AI; Cruz-Herrera J; Serralde-Zúñiga AE; Abdo-Francis JM; Gutiérrez-Reyes G; Pérez-Hernández JL
Ann Hepatol; 2014; 13(3):343-52. PubMed ID: 24756009
[TBL] [Abstract][Full Text] [Related]
29. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
[TBL] [Abstract][Full Text] [Related]
31. Drug therapy in alcoholism.
Kissin B; Gross MM
Curr Psychiatr Ther; 1970; 10():135-44. PubMed ID: 4319225
[No Abstract] [Full Text] [Related]
32. [Apomorphine in intoxication and abstinence therapy. A double-blind cross-over investigation of 40 ambulatory treated alcoholics].
Buus S; Christoffersen CB; Norregaard A
Ugeskr Laeger; 1974 Aug; 136(32):1808-13. PubMed ID: 4605512
[No Abstract] [Full Text] [Related]
33. [Metadoxyl in combined treatment of alcohol damage to the liver].
Vedrova NN; Gnezdilova NIu
Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
[TBL] [Abstract][Full Text] [Related]
34. Effects of Metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats.
Calabrese V; Calderone A; Ragusa N; Rizza V
Drugs Exp Clin Res; 1996; 22(1):17-24. PubMed ID: 8839633
[TBL] [Abstract][Full Text] [Related]
35. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
[TBL] [Abstract][Full Text] [Related]
36. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
37. Effect of pyrrolidone carboxylate (PCA) and pyridoxine on liver metabolism during chronic ethanol intake in rats.
Calabrese V; Ragusa N; Rizza V
Int J Tissue React; 1995; 17(1):15-20. PubMed ID: 7499060
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
39. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
Hantouche EG; Guelfi JD; Comet D
Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
[TBL] [Abstract][Full Text] [Related]
40. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study.
Bøe MG; Mygland A; Salvesen R
Neurology; 2007 Jul; 69(1):26-31. PubMed ID: 17475943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
